Thus, we concluded that miR‐34a could negatively bind to cyclin I to activate the ATM/ATR/p53 signalling pathway, thus inhibiting the resistance of cell cycle arrest and reducing the inflammation of RA. This evidence concerns the gene TP53 and rheumatoid arthritis.